This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $29,013.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has an ultimate completion date of October 7, 2024. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $1,857.60 and a completion date of June 26, 2024. It is a delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
The federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,723.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $3,394.34. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,149.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with a completion date of November 27, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $3,957.68. The contract is a delivery order with an ultimate completion date of September 6, 2024. This award does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,149.12 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 16, 2025. The contract is not designated as a...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,087.80 and was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical agency. The contract, valued at $36,426.18, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,471.67, is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...